Últimas noticias sobre Tenon Medical (NASDAQ:TNON) Bolsa

Tenon Medical

Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants, and 3) SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.

Tenon Medical Inc

Trading Ideas

Health In Tech Shares Resume Trade, Then Halted Again, This Time To The Downside

<p>Whales with a lot of money to spend have taken a noticeably bearish stance on <strong>Citigroup</strong>.</p>
<p>Looking at options history for Citigroup (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) we detected 22 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 40% of the investors opened trades with bullish expectations and 59% with bearish.</p>
<p>From the overall spotted trades, 17 are puts, for a total amount of $1,338,929 and 5, calls, for a total amount of $403,959.</p>
<h3>Predicted Price Range</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $57.5 to $77.5 for Citigroup over the recent three months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Citigroup stands at 9225.15, with a total volume reaching 24,043.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Citigroup, situated within the strike price corridor from $57.5 to $77.5, throughout the last 30 days.</p>
<h3>Citigroup 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1734970537_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>C</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$2.34</td>
<td>$2.22</td>
<td>$2.3</td>
<td>$77.50</td>
<td>$230.0K</td>
<td>4.4K</td>
<td>0</td>
</tr>
<tr>
<td>C</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$2.58</td>
<td>$2.57</td>
<td>$2.58</td>
<td>$60.00</td>
<td>$184.0K</td>
<td>26.1K</td>
<td>718</td>
</tr>
<tr>
<td>C</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/27/24</td>
<td>$1.2</td>
<td>$1.16</td>
<td>$1.19</td>
<td>$70.00</td>
<td>$154.8K</td>
<td>2.2K</td>
<td>2.0K</td>
</tr>
<tr>
<td>C</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$2.7</td>
<td>$2.69</td>
<td>$2.7</td>
<td>$62.50</td>
<td>$153.1K</td>
<td>770</td>
<td>567</td>
</tr>
<tr>
<td>C</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$2.72</td>
<td>$2.71</td>
<td>$2.72</td>
<td>$62.50</td>
<td>$136.5K</td>
<td>770</td>
<td>567</td>
</tr>
</tbody>
</table>
</p>
<h3>About Citigroup</h3>
<p>Citigroup is a global financial-services company doing business in more than 100 countries and jurisdictions. Citigroup's operations are organized into five primary segments: services, markets, banking, US personal banking, and wealth management. The bank's primary services include cross-border banking needs for multinational corporates, investment banking and trading, and credit card services in the United States.</p>
<p>Having examined the options trading patterns of Citigroup, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Citigroup's Current Market Status</h3>
<ul>
<li>With a volume of 1,896,254, the price of C is down -0.26% at $69.01. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 23 days.</li>
</ul>
<h3>Expert Opinions on Citigroup</h3>
<p>Over the past month, 4 industry analysts have shared their insights on this stock, proposing an average target price of $83.25.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on Citigroup with a target price of $90.<br />
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Overweight rating for Citigroup, targeting a price of $80.<br />
&#x2A; Showing optimism, an analyst from Keefe, Bruyette &amp; Woods upgrades its rating to Outperform with a revised price target of $82.<br />
&#x2A; An analyst from Goldman Sachs has decided to maintain their Buy rating on Citigroup, which currently sits at a price target of $81. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Citigroup options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Options

Markets

A Closer Look at Citigroup's Options Market Dynamics

<p>Investors with a lot of money to spend have taken a bearish stance on <strong>Spotify Technology</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>).</p>
<p>And retail traders should know.</p>
<p>We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.</p>
<p>Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with SPOT, it often means somebody knows something is about to happen.</p>
<p>So how do we know what these investors just did? </p>
<p>Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 16 uncommon options trades for Spotify Technology.</p>
<p>This isn't normal.</p>
<p>The overall sentiment of these big-money traders is split between 25% bullish and 43%, bearish.</p>
<p>Out of all of the special options we uncovered, 8 are puts, for a total amount of $684,088, and 8 are calls, for a total amount of $845,005.</p>
<h3>Expected Price Movements</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $340.0 to $490.0 for Spotify Technology during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Spotify Technology's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Spotify Technology's whale trades within a strike price range from $340.0 to $490.0 in the last 30 days. </p>
<h3>Spotify Technology 30-Day Option Volume &amp; Interest Snapshot</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1734970532_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>SPOT</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$40.75</td>
<td>$39.65</td>
<td>$40.28</td>
<td>$460.00</td>
<td>$402.8K</td>
<td align="right">909</td>
<td align="right">100</td>
</tr>
<tr>
<td>SPOT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$71.1</td>
<td>$70.0</td>
<td>$71.1</td>
<td>$490.00</td>
<td>$156.4K</td>
<td align="right">19</td>
<td align="right">57</td>
</tr>
<tr>
<td>SPOT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$132.75</td>
<td>$126.5</td>
<td>$130.75</td>
<td>$340.00</td>
<td>$130.7K</td>
<td align="right">55</td>
<td align="right">0</td>
</tr>
<tr>
<td>SPOT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$31.4</td>
<td>$30.3</td>
<td>$30.3</td>
<td>$480.00</td>
<td>$106.0K</td>
<td align="right">497</td>
<td align="right">123</td>
</tr>
<tr>
<td>SPOT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$27.15</td>
<td>$26.05</td>
<td>$27.15</td>
<td>$480.00</td>
<td>$86.8K</td>
<td align="right">497</td>
<td align="right">78</td>
</tr>
</tbody>
</table>
</p>
<h3>About Spotify Technology</h3>
<p>Spotify is the leading global music streaming service provider, with over 600 million monthly active users and 250 million paying subscribers, with the latter comprising the firm's premium segment. most of the firm's revenue and nearly all its gross profit come from the subscribers, who pay a monthly fee to access a very comprehensive music library that consists of most of the most popular songs ever recorded, including all from the major record labels. The firm also sells separate audiobook subscriptions and integrates podcasts within its standard music app. Podcast content is not exclusive and is typically free to access on other platforms. Ad-supported users can access a similar music catalog but cannot customize a similar on-demand experience.</p>
<p>After a thorough review of the options trading surrounding Spotify Technology, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Spotify Technology's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 392,062, the SPOT's price is down by -1.31%, now at $454.83. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 43 days.</li>
</ul>
<h3>Professional Analyst Ratings for Spotify Technology</h3>
<p>In the last month, 1 experts released ratings on this stock with an average target price of $560.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Canaccord Genuity has decided to maintain their Buy rating on Spotify Technology, which currently sits at a price target of $560. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Spotify Technology options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


SPOT

A Closer Look at Spotify Technology's Options Market Dynamics

<p>Financial giants have made a conspicuous bearish move on Snowflake. Our analysis of options history for Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) revealed 21 unusual trades.</p>
<p>Delving into the details, we found 23% of traders were bullish, while 47% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $149,740, and 17 were calls, valued at $1,233,994.</p>
<h3>What's The Price Target?</h3>
<p>Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $65.0 to $210.0 for Snowflake over the recent three months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Snowflake's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Snowflake's significant trades, within a strike price range of $65.0 to $210.0, over the past month.</p>
<h3>Snowflake Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1734970527_0.png" alt="Options Call Chart" /></p>
<h3>Largest Options Trades Observed:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$25.6</td>
<td>$25.15</td>
<td>$25.35</td>
<td>$160.00</td>
<td>$134.3K</td>
<td>1.4K</td>
<td>114</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$25.65</td>
<td>$25.1</td>
<td>$25.28</td>
<td>$160.00</td>
<td>$128.9K</td>
<td>1.4K</td>
<td>61</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$59.5</td>
<td>$54.1</td>
<td>$56.9</td>
<td>$110.00</td>
<td>$113.8K</td>
<td>395</td>
<td>22</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$22.25</td>
<td>$21.3</td>
<td>$21.39</td>
<td>$200.00</td>
<td>$106.9K</td>
<td>4.5K</td>
<td>59</td>
</tr>
<tr>
<td>SNOW</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$0.69</td>
<td>$0.68</td>
<td>$0.69</td>
<td>$190.00</td>
<td>$105.7K</td>
<td>8.6K</td>
<td>1.6K</td>
</tr>
</tbody>
</table>
</p>
<h3>About Snowflake</h3>
<p>Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that went public in 2020. To date, the company has over 3,000 customers, including nearly 30% of the Fortune 500. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to buy and ingest data, while its data solutions can be hosted on various public clouds.</p>
<p>In light of the recent options history for Snowflake, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Present Market Standing of Snowflake</h3>
<ul>
<li>Trading volume stands at 1,475,165, with SNOW's price down by -2.92%, positioned at $161.43.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 65 days.</li>
</ul>
<h3>What The Experts Say On Snowflake</h3>
<p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $195.0.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Wedbush has elevated its stance to Outperform, setting a new price target at $190.<br />
&#x2A; In a cautious move, an analyst from JMP Securities downgraded its rating to Market Outperform, setting a price target of $190.<br />
&#x2A; An analyst from Loop Capital persists with their Buy rating on Snowflake, maintaining a target price of $205.<br />
&#x2A; An analyst from Barclays persists with their Equal-Weight rating on Snowflake, maintaining a target price of $190.<br />
&#x2A; An analyst from Jefferies has decided to maintain their Buy rating on Snowflake, which currently sits at a price target of $200. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Snowflake, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


SNOW

A Closer Look at Snowflake's Options Market Dynamics

DRCT

Direct Digital Shares Resume Trade Then Again Halted On Circuit Breaker To The Upside, Stock Now Up 290.9%

<p><strong>Vertex Pharmaceuticals Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) last week announced that the Phase 2 study of suzetrigine for painful lumbosacral radiculopathy (LSR) had <a href="https://www.benzinga.com/24/12/42599745/why-is-vertex-pharmaceuticals-stock-trading-on-thursday-lower-after-back-pain-trial-data">met its primary endpoint</a>.<strong></strong></p>
<p>The company announced that the FDA had approved Alyftrek (or vanzacaftor triple) in cystic fibroris (CF) six years and older, in-line with expectations, according to Goldman Sachs.<strong></strong></p>
<p><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587781dc5064ed0001730067/salveen-richter">Analyst Salveen Richter</a> maintained a Buy rating for Vertex Pharmaceuticals<strong> </strong>and price target of $602.</p>
<p><strong>The </strong><strong>Vertex Pharmaceuticals </strong><strong>Thesis:</strong> During the initial launch of Alyftrek, the company is likely to target those patients who had previously started on one of its CFTR modulators but have discontinued over time, Richter said in the note.</p>
<p>Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.</p>
<p>Alyftrek expands the company's CF franchise to address around 6,000 such patients, he added.</p>
<p>Vertex Pharmaceuticals could also target patients who are currently on one of its other CF therapies, the analyst stated.</p>
<p>"Importantly, in addition to serving as a top-line growth opportunity, vanzacaftor enables higher margins and is dosed once daily, which provides incentive for switching notably in younger age groups," Richter wrote. This means Alyftrek provides the company with an "accretive opportunity" on both the top- and bottom-lines, he further said.</p>
<p><strong>VRTX Price Action:</strong> Shares of Vertex Pharmaceuticals<strong> </strong>had declined by 0.38% to $395.75 at the time of publication on Monday late morning.</p>
<p><strong>Read More: </strong><strong><a href="https://www.benzinga.com/news/large-cap/24/12/42638379/novo-nordisk-super-micro-computer-and-arm-are-among-top-large-cap-losers-last-week-december-16-20-are-the-others-in-your-portfolio">Novo Nordisk, Super Micro Computer And Arm Are Among Top Large Cap Losers Last Week (December 16-20): Are The Others In Your Portfolio?</a></strong><strong></strong></p>



Analyst Color

Long Ideas

Reiteration

Analyst Ratings

VRTX

Vertex Pharmaceuticals: Alyftrek Is An 'Accretive Opportunity' On Top- And Bottom-Lines, Says Bullish Analyst

Health In Tech Shares Halted

<p>Roth MKM  analyst Mike Niehuser   maintains Tudor Gold (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/TUD#TSXV">TUD</a>) with a Buy and lowers the price target from C$3 to C$2.</p>


News

Price Target

TSXV:TUD

Roth MKM Maintains Buy on Tudor Gold, Lowers Price Target to C$2

IPOs

Health In Tech Shares Open For Trade At $5.25 Per Share; IPO Priced At $4.00 Per Share

<p><strong>MicroStrategy Inc.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) has further increased its holdings by purchasing 5,262 <strong>Bitcoin</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) at an average price of $106,662, totaling approximately $561 million.</p>
<p><strong>What Happened: </strong>This <a href="https://assets.contentstack.io/v3/assets/bltb564490bc5201f31/blt0ec5bb8a309ff033/67695cb1b1ed3c2aa7dc573e/form-8-k_12-23-2024.pdf">acquisition</a> brings MicroStrategy's total Bitcoin holdings to 444,262 BTC, with an average cost of $62,257 and a total cost of approximately $27.7 billion as of Dec. 22, 2024.</p>
<p>This latest purchase by MicroStrategy comes at a time of market speculation about a potential pause in their <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42617815/are-microstrategys-bitcoin-purchases-on-hold-in-january">Bitcoin-buying strategy next month</a>.</p>
<p>This speculation centers around the idea that the company might temporarily halt its practice of issuing convertible debt or selling shares through &#8220;at-the-market&#8221; programs to fund these acquisitions. </p>
<p>It is believed that these activities might be put on hold as the company prepares for the release of its earnings report in early February 2025. </p>
<p>A venture capitalist initially raised concerns about a potential restriction on the company issuing new convertible debt in January, which has spurred a great amount of discussion among investors.</p>
<p>While MicroStrategy has not confirmed or denied these rumors, it is generally understood that companies often implement self-imposed blackout periods to ensure compliance with trading regulations. </p>
<p><strong>Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42647239/foresight-ventures-55m-investment-in-the-block-seeks-to-shape-the-future-of-crypto-media-forest-bai">Foresight Ventures&#8217; $55M Investment In The Block Seeks To Shape The Future Of Crypto Media: Forest Bai</a></strong></p>
<p>These periods usually occur near the end of a fiscal quarter and before the public release of earnings, thus limiting access to non-public information for insider trading purposes. </p>
<p>The SEC does not require these blackout periods, but companies implement them to maintain trust and integrity with the shareholders. </p>
<p>These financial blackout periods may apply to either ATM share sales, convertible debt offerings, or both and that information is not currently clear. </p>
<p>These potential restrictions on Bitcoin purchases have put a spotlight on MicroStrategy's funding strategies.</p>
<p>Some analysts believe the timing of the rumored blackout aligns with MicroStrategy&#8217;s upcoming earnings report between Feb. 3-5, 2025, and could be a result of common precautions that businesses adopt before publicly releasing financial information. </p>
<p>Furthermore, the company&#8217;s inclusion in the NASDAQ 100 index on Dec. 23 could also play a part, as this often leads companies to reassess their practices around governance and public disclosures. </p>
<p>Any decision about a blackout period is ultimately decided by MicroStrategy&#8217;s board of directors, reflecting the importance of regulatory adherence.</p>
<p><strong>Read Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42644568/institutional-crypto-adoption-for-real-this-time-says-messari">Institutional Crypto Adoption &#8216;For Real This Time,&#8217; Says Messari</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

MSTR

MicroStrategy Adds 5,262 Bitcoin To Bring Holdings To Over 444,000 BTC

NVDA

NVIDIA Option Alert: 4,353 Jan 17 $140 Calls Swept Near Ask At $5.651 With 128,293 Open Interest; Underlying Stock At $137.34

<p>Roth MKM  analyst Sean McGowan   maintains MGP Ingredients (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGPI#NASDAQ">MGPI</a>) with a Buy and lowers the price target from $65 to $60.</p>


MGPI

Roth MKM Maintains Buy on MGP Ingredients, Lowers Price Target to $60

<p>The Office of the Comptroller of the Currency (OCC) today issued a cease-and-desist order (order) against Bank of America, N.A. (bank) for deficiencies related to its Bank Secrecy Act (BSA) and sanctions compliance programs.</p>
<p><a href="https://occ.gov/news-issuances/news-releases/2024/nr-occ-2024-140.html" title="https://occ.gov/news-issuances/news-releases/2024/nr-occ-2024-140.html">https://occ.gov/news-issuances/news-releases/2024/nr-occ-2024-140.html</a></p>


'OCC Issues Cease and Desist Order Against Bank of America for BSA Deficiencies' - OCC

Direct Digital Shares Resume Trade Then Again Halted On Circuit Breaker To The Upside, Stock Now Up 256.4%

<p>Financial giants have made a conspicuous bearish move on Applied Optoelectronics. Our analysis of options history for Applied Optoelectronics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAOI#NASDAQ">AAOI</a>) revealed 21 unusual trades.</p>
<p>Delving into the details, we found 38% of traders were bullish, while 47% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $432,603, and 15 were calls, valued at $986,947.</p>
<h3>Projected Price Targets</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $22.5 to $50.0 for Applied Optoelectronics during the past quarter. </p>
<h3>Volume &amp; Open Interest Trends</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for Applied Optoelectronics's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Applied Optoelectronics's whale activity within a strike price range from $22.5 to $50.0 in the last 30 days. </p>
<h3>Applied Optoelectronics Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1734969631_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>AAOI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$17.5</td>
<td>$16.5</td>
<td>$17.4</td>
<td>$22.50</td>
<td>$132.2K</td>
<td>1.7K</td>
<td align="right">46</td>
</tr>
<tr>
<td>AAOI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$6.5</td>
<td>$6.2</td>
<td>$6.5</td>
<td>$35.00</td>
<td>$130.0K</td>
<td>2.8K</td>
<td align="right">205</td>
</tr>
<tr>
<td>AAOI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>02/21/25</td>
<td>$5.7</td>
<td>$5.4</td>
<td>$5.62</td>
<td>$35.00</td>
<td>$113.3K</td>
<td>2</td>
<td align="right">447</td>
</tr>
<tr>
<td>AAOI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$6.7</td>
<td>$6.2</td>
<td>$6.5</td>
<td>$45.00</td>
<td>$97.5K</td>
<td>1.3K</td>
<td align="right">250</td>
</tr>
<tr>
<td>AAOI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$5.7</td>
<td>$5.5</td>
<td>$5.65</td>
<td>$35.00</td>
<td>$92.8K</td>
<td>2</td>
<td align="right">808</td>
</tr>
</tbody>
</table>
</p>
<h3>About Applied Optoelectronics</h3>
<p>Applied Optoelectronics Inc is a provider of fiber-optic networking products for the Internet data center, cable television, telecommunications and fiber-to-the-home end markets. The company focuses on designing and manufacturing a range of optical communication products from components, to subassemblies, and modules to complete turn-key equipment. Demand for Applied Optoelectronics is driven by bandwidth demand in end markets. Through direct sales personnel, and manufacturing teams in the United States, China, and Taiwan, the company coordinates with customers to determine product design, qualifications, and performance. The company derives maximum revenue from Taiwan.</p>
<p>In light of the recent options history for Applied Optoelectronics, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Where Is Applied Optoelectronics Standing Right Now?</h3>
<ul>
<li>With a trading volume of 1,020,369, the price of AAOI is down by -2.23%, reaching $36.98.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 59 days from now.</li>
</ul>
<h3>Expert Opinions on Applied Optoelectronics</h3>
<p>4 market experts have recently issued ratings for this stock, with a consensus target price of $34.25.</p>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; In a cautious move, an analyst from Northland Capital Markets downgraded its rating to Outperform, setting a price target of $40.<br />
&#x2A; An analyst from Rosenblatt persists with their Buy rating on Applied Optoelectronics, maintaining a target price of $44.<br />
&#x2A; An analyst from B. Riley Securities has revised its rating downward to Sell, adjusting the price target to $14.<br />
&#x2A; An analyst from Raymond James persists with their Outperform rating on Applied Optoelectronics, maintaining a target price of $39. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Applied Optoelectronics, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.</p>


AAOI

Applied Optoelectronics's Options Frenzy: What You Need to Know

<p>Financial giants have made a conspicuous bullish move on CrowdStrike Holdings. Our analysis of options history for CrowdStrike Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRWD#NASDAQ">CRWD</a>) revealed 19 unusual trades.</p>
<p>Delving into the details, we found 52% of traders were bullish, while 31% showed bearish tendencies. Out of all the trades we spotted, 6 were puts, with a value of $776,760, and 13 were calls, valued at $1,132,509.</p>
<h3>Predicted Price Range</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $90.0 and $390.0 for CrowdStrike Holdings, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.</p>
<p>This data can help you track the liquidity and interest for CrowdStrike Holdings's options for a given strike price.</p>
<p>Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of CrowdStrike Holdings's whale activity within a strike price range from $90.0 to $390.0 in the last 30 days. </p>
<h3>CrowdStrike Holdings Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1734969626_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CRWD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/31/25</td>
<td>$5.35</td>
<td>$3.0</td>
<td>$3.05</td>
<td>$305.00</td>
<td>$518.5K</td>
<td>4</td>
<td>1.7K</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$160.5</td>
<td>$157.55</td>
<td>$158.05</td>
<td>$250.00</td>
<td>$316.1K</td>
<td>62</td>
<td>20</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$148.45</td>
<td>$144.05</td>
<td>$146.75</td>
<td>$270.00</td>
<td>$293.5K</td>
<td>45</td>
<td>20</td>
</tr>
<tr>
<td>CRWD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$81.8</td>
<td>$79.85</td>
<td>$81.8</td>
<td>$340.00</td>
<td>$89.9K</td>
<td>491</td>
<td>11</td>
</tr>
<tr>
<td>CRWD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$1.36</td>
<td>$1.35</td>
<td>$1.36</td>
<td>$300.00</td>
<td>$85.1K</td>
<td>5.0K</td>
<td>635</td>
</tr>
</tbody>
</table>
</p>
<h3>About CrowdStrike Holdings</h3>
<p>CrowdStrike is a cloud-based cybersecurity company specializing in next-generation security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform that offers a proverbial single pane of glass for an enterprise to detect and respond to security threats attacking its IT infrastructure. The Texas-based firm was founded in 2011 and went public in 2019.</p>
<p>Having examined the options trading patterns of CrowdStrike Holdings, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>CrowdStrike Holdings's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 1,143,560, the CRWD's price is down by -1.04%, now at $358.51. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 71 days.</li>
</ul>
<h3>Expert Opinions on CrowdStrike Holdings</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $398.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from RBC Capital has decided to maintain their Outperform rating on CrowdStrike Holdings, which currently sits at a price target of $365.<br />
&#x2A; Consistent in their evaluation, an analyst from Citigroup keeps a Buy rating on CrowdStrike Holdings with a target price of $400.<br />
&#x2A; Consistent in their evaluation, an analyst from Evercore ISI Group keeps a Outperform rating on CrowdStrike Holdings with a target price of $400.<br />
&#x2A; Consistent in their evaluation, an analyst from Jefferies keeps a Buy rating on CrowdStrike Holdings with a target price of $450.<br />
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Overweight rating for CrowdStrike Holdings, targeting a price of $375. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest CrowdStrike Holdings options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


CRWD

Check Out What Whales Are Doing With CRWD

<p>Financial giants have made a conspicuous bearish move on Newmont. Our analysis of options history for Newmont (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEM#NYSE">NEM</a>) revealed 17 unusual trades.</p>
<p>Delving into the details, we found 41% of traders were bullish, while 58% showed bearish tendencies. Out of all the trades we spotted, 10 were puts, with a value of $1,501,139, and 7 were calls, valued at $711,269.</p>
<h3>What's The Price Target?</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $35.0 to $55.0 for Newmont over the last 3 months. </p>
<h3>Insights into Volume &amp; Open Interest</h3>
<p>In today's trading context, the average open interest for options of Newmont stands at 2141.25, with a total volume reaching 3,328.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Newmont, situated within the strike price corridor from $35.0 to $55.0, throughout the last 30 days.</p>
<h3>Newmont Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1734969621_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>NEM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/17/25</td>
<td>$17.3</td>
<td>$17.15</td>
<td>$17.25</td>
<td>$55.00</td>
<td>$391.5K</td>
<td>118</td>
<td align="right">228</td>
</tr>
<tr>
<td>NEM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>10/17/25</td>
<td>$17.5</td>
<td>$17.4</td>
<td>$17.5</td>
<td>$55.00</td>
<td>$322.0K</td>
<td>118</td>
<td align="right">436</td>
</tr>
<tr>
<td>NEM</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$6.0</td>
<td>$4.95</td>
<td>$6.0</td>
<td>$37.50</td>
<td>$300.6K</td>
<td>8.9K</td>
<td align="right">510</td>
</tr>
<tr>
<td>NEM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$8.65</td>
<td>$8.55</td>
<td>$8.65</td>
<td>$45.00</td>
<td>$257.7K</td>
<td>4.8K</td>
<td align="right">302</td>
</tr>
<tr>
<td>NEM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$6.35</td>
<td>$6.25</td>
<td>$6.35</td>
<td>$42.50</td>
<td>$173.3K</td>
<td>3.1K</td>
<td align="right">300</td>
</tr>
</tbody>
</table>
</p>
<h3>About Newmont</h3>
<p>Newmont is the world's largest gold miner. It bought Goldcorp in 2019, combined its Nevada mines in a joint venture with competitor Barrick later that year, and also purchased competitor Newcrest in November 2023. Its portfolio includes 17 wholly or majority owned mines and interests in two joint ventures in the Americas, Africa, Australia and Papua New Guinea. The company is expected to produce roughly 5.5 million ounces of gold in 2024 from its core mines and 6.8 million in total. It is likely to sell a number of its higher cost, smaller mines accounting for 20% of forecast sales in 2024. Newmont also produces material amounts of copper, silver, zinc, and lead as byproducts. It had about two decades of gold reserves along with significant byproduct reserves at the end of December 2023.</p>
<p>In light of the recent options history for Newmont, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Current Position of Newmont</h3>
<ul>
<li>Currently trading with a volume of 1,927,050, the NEM's price is down by -1.89%, now at $37.55. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 59 days.</li>
</ul>
<p><strong>Turn $1000 into $1270 in just 20 days?</strong></p>
<p>20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights"><strong>Click here for access</strong></a>.</p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Newmont options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


This Is What Whales Are Betting On Newmont

<p>Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) has outperformed the market over the past 10 years by 28.92% on an annualized basis producing an average annual return of 39.92%. Currently, Tesla has a market capitalization of $1.37 trillion. </p>
<p><strong>Buying $1000 In TSLA:</strong> If an investor had bought $1000 of TSLA stock 10 years ago, it would be worth <strong>$28,316.31</strong> today based on a price of $425.27 for TSLA at the time of writing.</p>
<h3>Tesla's Performance Over Last 10 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1734969609_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


TSLA

$1000 Invested In Tesla 10 Years Ago Would Be Worth This Much Today

Trident Acquisitions Corp Units (1 Ord & 1 War)

TDACU

Trading Halt: Halt status updated at 11:00:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation

<p>Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.</p>
<ul>
<li>Loop Capital increased <strong>Microsoft Corporation</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) price target from $500 to $550. Loop Capital analyst Eric Beder maintained a Buy rating. Microsoft shares closed at $436.60 on Friday. See how other analysts view this stock.</li>
<li>Truist Securities cut the price target for <strong>Vertex Pharmaceuticals Incorporated</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) from $550 to $460. Truist Securities analyst Joon Lee maintained a Buy rating. Vertex Pharmaceuticals shares closed at $397.27 on Friday. See how other analysts view this stock.</li>
<li>Goldman Sachs lowered the price target for <strong>Lennar Corporation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) from $190 to $162. Goldman Sachs analyst Susan Maklari maintained a Neutral rating. Lennar shares closed at $138.08 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Benchmark boosted the price target for <strong>Humacyte, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HUMA#NASDAQ">HUMA</a>) from $15 to $17. Benchmark analyst Bruce Jackson maintained a Buy rating. Humacyte shares closed at $4.64 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Loop Capital <strong>Snowflake Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) price target from $185 to $205. Loop Capital analyst Mark Schappel maintained a Buy rating. Snowflake shares settled at $166.29 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>RBC Capital raised <strong>Uniti Group Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UNIT#NASDAQ">UNIT</a>) price target from $5.5 to $6. RBC Capital analyst Bora Lee maintained a Sector Perform rating. Uniti shares closed at $5.70 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Loop Capital increased <strong>Datadog, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>) price target from $160 to $200. Loop Capital analyst Yun Kim maintained a Buy rating. Datadog shares closed at $149.46 on Friday.  <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Stifel cut the price target for <strong>Schlumberger Limited</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) from $60 to $59. Stifel analyst Stephen Gengaro maintained a Buy rating. Schlumberger shares settled at $36.83 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays raised <strong>Carnival Corporation</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) price target from $31 to $32. Barclays analyst Brandt Montour maintained an Overweight rating. Carnival shares closed at $26.80 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. increased <strong>SoundHound AI, Inc</strong>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) price target from $8 to $26. HC Wainwright &amp; Co. analyst Scott Buck maintained a Buy rating. SoundHound AI shares closed at $21.75 on Friday. <a href="https://www.benzinga.com/quote/MSFT/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
<p><strong>Read This Next: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42616196/jim-cramer-likes-walmart-recommends-buying-this-very-very-good-financial-stock">Jim Cramer Likes Walmart, Recommends Buying This &#8216;Very, Very Good&#8217; Financial Stock</a></strong></li>
</ul>


DDOG

HUMA

MSFT

SOUN

UNIT

Microsoft To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Monday

An update from Tenon Medical, Inc. ( ($TNON) ) is now available. Tenon Medical, Inc. has successfully closed a $4.5 million public offering, manage...

Tenon Medical Secures Funding to Expand Fusion System Operations

IBKR's 25 most actively traded stocks ranked by SA's Quant Metrics

Tenon Medical files to sell 2.4M shares of common stock for holders

Tenon Medical regains compliance with Nasdaq

Tenon Medical (TNON) is in compliance with all relevant Nasdaq continued listing Rules. The Company had previously reported non compliance with Nas...

Tenon Medical regains full compliance with Nasdaq listing rules

Tenon Medical GAAP EPS of -$3.63, revenue of $0.88M misses by $0.38M

Reports Q3 revenue $900K, consensus $1.19M.teve Foster, President and Chief Executive Officer of Tenon Medical (TNON), commented, "During the third...

Tenon Medical reports Q3 EPS ($3.63), consensus ($4.23)

Tenon Medical, Inc. (TNON) Q3 2024 Earnings Call Transcript

Tenon Medical, Inc. ( ($TNON) ) has released its Q3 earnings. Here is a breakdown of the information Tenon Medical, Inc. presented to its investors...

Tenon Medical's Q3 2024 Earnings and Strategic Progress

Maxim lowered the firm's price target on Tenon Medical (TNON) to $8 from $22 but keeps a Buy rating on the shares. The company's Q3 revenue missed ...

Tenon Medical price target lowered to $8 from $22 at Maxim

AAPL

AMZN

ASTS

AVGO

GOOGL

INTC

NVDL

ORCL

PLTR

SMCI

SOXL

SOXS

SQQQ

TNON

TNONW

TQQQ

Press Releases

Tenon(R) Medical Announces the Introduction of the Catamaran(R) SE SI Joint Fusion System

Tenon Medical, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Tenon Medical, Inc. Announces Closing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Tenon Medical Announces Issuance of Three Notices of Allowance for Patent Applications from the USPTO

Tenon Medical(R) Announces Issuance of Three U.S. Patents

Tenon Medical(R) Regains Full Compliance with Nasdaq Continued Listing Requirements

Tenon Medical, Inc. Announces Timing of Third Quarter 2024 Financial Results

Tenon Medical Announces Initial Clinical Cases Successfully Completed with Company's New Catamaran(R) SE SI Joint Fusion System

"The Future is Bright: Peraso Inc. (NASDAQ: PRSO) Expands Technology for Tactical Applications in High-Demand Industries – More Stocks Inside…"

Comments

Tenon Medical

Noticias

Últimas noticias sobre Tenon Medical (NASDAQ:TNON) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL